Indian Pharma Market Grew 12.1% In August, AWACS Report

New Delhi : Indian pharmaceutical market (IPM) grew 12.1% in value and 4.8% in volumes, in the month of August on back of strong growth across all the therapy areas, according to market research firm AWACS.

IPM saw sales of Rs 16,239 crore during August.

The wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on drugs under price control, along with monsoon linked infectious diseases.

The fastest growing categories are cardiac which grew at 13%, anti-infectives – 13% and gastrointestinal – 12%. Anti-diabetes and vitamins grew 9% respectively.

Augmentin of GSK, Glycomet of USV and Mixtard of Abbott, remain top-3 selling brands in India.

  • Related Posts

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

    Spurious cosmetic packaging factory busted in northwest Delhi

    New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Spurious cosmetic packaging factory busted in northwest Delhi

    Spurious cosmetic packaging factory busted in northwest Delhi

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    UP plans US FDA-accredited medical device testing lab

    UP plans US FDA-accredited medical device testing lab

    Patent rejected for MNC’s cancer drug, generics to follow

    Patent rejected for MNC’s cancer drug, generics to follow

    Zydus brings world’s first Nivolumab biosimilar to India

    Zydus brings world’s first Nivolumab biosimilar to India